$67.7 Million is the total value of Trustees of Columbia University in the City of New York's 14 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 52.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $32,651,000 | +8.5% | 78 | 0.0% | 48.23% | +32.3% | |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $13,489,000 | +10.9% | 278,127 | -11.2% | 19.92% | +35.1% |
| SANA | SANA BIOTECHNOLOGY INC | $5,530,000 | -41.3% | 281,250 | 0.0% | 8.17% | -28.4% | |
| VOR | VOR BIOPHARMA INC | $3,428,000 | -56.7% | 183,821 | 0.0% | 5.06% | -47.3% | |
| ASAN | Buy | ASANA INCcl a | $2,660,000 | +357.8% | 42,888 | +111.0% | 3.93% | +458.1% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $2,486,000 | +52.6% | 78,210 | +6.6% | 3.67% | +86.0% |
| EVLO | EVELO BIOSCIENCES INC | $1,564,000 | +28.4% | 113,850 | 0.0% | 2.31% | +56.5% | |
| SFIX | New | STITCH FIX INC | $1,547,000 | – | 25,652 | +100.0% | 2.28% | – |
| MSFT | MICROSOFT CORP | $1,267,000 | +14.9% | 4,678 | 0.0% | 1.87% | +39.9% | |
| KLDO | KALEIDO BIOSCIENCES INC | $1,117,000 | -8.1% | 150,150 | 0.0% | 1.65% | +11.9% | |
| ZEN | New | ZENDESK INC | $663,000 | – | 4,591 | +100.0% | 0.98% | – |
| PGNY | Buy | PROGYNY INC | $579,000 | +40.9% | 9,808 | +6.3% | 0.86% | +71.7% |
| SNOW | New | SNOWFLAKE INCcl a | $415,000 | – | 1,716 | +100.0% | 0.61% | – |
| BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $306,000 | +8.5% | 1,100 | 0.0% | 0.45% | +32.2% | |
| AM | Exit | ANTERO MIDSTREAM CORP | $0 | – | -11,130 | -100.0% | -0.12% | – |
| AR | Exit | ANTERO RESOURCES CORP | $0 | – | -41,633 | -100.0% | -0.52% | – |
| TWLO | Exit | TWILIO INCcl a | $0 | – | -1,380 | -100.0% | -0.57% | – |
| DASH | Exit | DOORDASH INCcl a | $0 | – | -7,040 | -100.0% | -1.12% | – |
| BIGC | Exit | BIGCOMMERCE HLDGS INC | $0 | – | -25,065 | -100.0% | -1.76% | – |
| ACCD | Exit | ACCOLADE INC | $0 | – | -288,892 | -100.0% | -15.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 8 | Q3 2023 | 74.3% |
| RAPT THERAPEUTICS INC | 8 | Q3 2023 | 3.7% |
| BERKSHIRE HATHAWAY INC DEL | 8 | Q3 2023 | 0.7% |
| VOR BIOPHARMA INC | 7 | Q3 2023 | 9.6% |
| EVELO BIOSCIENCES INC | 6 | Q1 2023 | 2.3% |
| TENAYA THERAPEUTICS INC | 5 | Q3 2023 | 9.2% |
| SURROZEN INC | 5 | Q3 2023 | 7.8% |
| SURROZEN INC | 5 | Q3 2023 | 0.1% |
| SANA BIOTECHNOLOGY INC | 4 | Q3 2023 | 11.4% |
| DISC MEDICINE INC | 4 | Q3 2023 | 7.2% |
View Trustees of Columbia University in the City of New York's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
View Trustees of Columbia University in the City of New York's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.